论文信息 - Broad Activity for the Pivekimab Sunirine (PVEK, IMGN632), Azacitidine, and Venetoclax Triplet in High-Risk Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) - 字舞流文

Broad Activity for the Pivekimab Sunirine (PVEK, IMGN632), Azacitidine, and Venetoclax Triplet in High-Risk Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML)

P. Vyas | M. Konopleva | G. Gaidano | N. Daver | G. Marcucci | X. Thomas | N. Pemmaraju | A. Advani | J. Altman | C. Récher | N. Vey | N. Boissel | R. Walter | G. Roboz | U. Platzbecker | E. Wang | H. Erba | K. Begna | A. Curti | K. Sweet | L. Mendez | P. Zweidler-McKay | D. Sallman | C. Schliemann | P. Montesinos | E. Todisco | G. Marconi | H. Kantarjian | D. Jeyakumar | A. de la Fuente | A. Aribi | L. Gastaud | C. Sloss | Giovanni Martinelli | Daniel J. DeAngelo | P. Burke | Laura Torres | S. Kapp-Schwoerer | Thomas Longval | Kara E. Malcolm | Kara E Malcolm